Australia markets closed

Clarus Therapeutics Holdings, Inc. (CRXT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.3914-0.0236 (-5.69%)
At close: 04:00PM EDT
0.4100 +0.02 (+4.75%)
After hours: 07:58PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts4444
Avg. Estimate-0.29-0.24-1.18-0.62
Low estimate-0.36-0.29-1.33-0.75
High estimate-0.22-0.17-0.94-0.5
Year ago EPSN/A-0.26-5.72-1.18
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3344
Avg. Estimate5.1M6.56M23.67M45.32M
Low estimate4.39M5.3M20M38.8M
High estimate6.3M7.8M28.9M55.8M
Year ago sales2.78M4.29M13.96M23.67M
Sales growth (year/est)83.50%53.10%69.60%91.50%
Earnings historyInvalid Date29/09/202130/12/202130/03/2022
Est. EPSN/A-0.81-0.68-0.4
Actual EPSN/A-0.26-0.19-0.61
DifferenceN/A0.550.49-0.21
Surprise %N/A67.90%72.10%-52.50%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.29-0.24-1.18-0.62
7 days ago-0.26-0.24-1.13-0.58
30 days ago-0.26-0.24-1.13-0.58
60 days ago-0.44-0.45-1.8-1.27
90 days ago-0.62-0.54-2.3-0.76
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 days111N/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCRXTIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.7.70%N/AN/AN/A
Current year79.40%N/AN/AN/A
Next year47.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A